• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
    • About Us
    • Founding Team
  • Blog
  • Drug Search
  • Zones
    • Suicide
    • Violence
    • Sex and Relationships
    • Hair
    • Skin and Nails
    • Withdrawal
    • Vision
    • Fertility
  • Research Fund
  • Tools
    • Healthcare Record Pro Forma
    • Starting a Medication
    • Guides & Papers
    • Too Many Medications?
    • Complex Withdrawal
    • Videos
    • Reducing the Risk of Treatment Induced Suicide
  • PSSD
    • Post-SSRI Sexual Dysfunction (PSSD)
    • PSSD Doctors
    • PSSD Literature
    • PSSD in the Media
    • RxISK Prize
    • Research Forum for Enduring Sexual Dysfunction
  • Side Effect?
RxISK Logo

RxISK

Making Medicines Safer for All of Us

AbbVie Petition: Drug Hazards are Not Trade Secrets

August 30, 2013 Leave a Comment

dangerous side effects

RxISK has started a petition on Change.org which will go to Richard Gonzalez CEO of AbbVie, and Daniel Welch CEO of InterMune, who are at present taking a legal action to block the European Medicines Agency’s policy of open access to clinical trial data.

The reason to petition is in this post Let’s do the AbbVie again and the Petition is Here.

Can you take 30 seconds to sign?

Petition

Let us see Drug Data! Drug hazards are not “trade secrets”!

Drug companies maximize the sales of new drugs by hyping their benefits while downplaying significant risks. In 2010 the European Medicines Agency began releasing patient-level data from the clinical trials used to approve new medicines in Europe – a development hailed by American, and European researchers and researchers around the world as a major step towards drug safety.

This process has been shut down by a lawsuit taken by two American corporations – AbbVie, makers of Humira, the number one selling medication in the world with projected sales of $10 billion in 2013; and InterMune, whose pulmonary-fibrosis drug Esbriet has recently been approved in Europe at a cost of over $40,000 per year.

AbbVie and InterMune have filed suit to deny access to the data from their trials on the benefits and harms of these drugs, claiming these vital facts are “trade secrets” whose release would harm their profits. Their action has led to the shutdown of the entire public-access program, leaving millions of patients worldwide, and their doctors, in the dark.

We call on AbbVie and InterMune to drop their European Union lawsuit and release all patient level data on Humira, Esbriet and their other products. Vital data on drug safety should never be hidden as a “trade secret.” By copying this petition to President Barack Obama and members of his Cabinet we call on them to ensure that meaningful public access to clinical trial data becomes the policy of the FDA and is written into any international trade agreements governing the sale of prescription drugs and devices.

Copies to:

  • President Barack Obama
  • Margaret Hamburg, M.D., Commissioner, Food & Drug Administration
  • Secretary General Ban Ki Moon, United Nations
  • World Health Organization Director Dr Margaret Chan

Filed Under: Petitions

Are you experiencing a drug side effect?

Get your free RxISK Report to find out

 

Subscribe to our mailing list
Get notified when we publish a new blog post.
By subscribing, you agree with our privacy policy and our terms of service.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • Who Knew Drugs could have Antibodies
  • Ostriches, Doctors, SSRIs and Tylenol
  • Withdrawal Syndromes: Lost in Translation
  • Over-Diagnosing or Under-Diagnosing
  • The Future of Health App-ointments

Blog Categories

Footer

Contact

Media Contact

Terms | Privacy

Follow us

  • Facebook
  • Twitter

Search

Copyright © 2025 · Data Based Medicine Global Ltd.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok